Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV
Clicks: 5
ID: 321915
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
5 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #61 of 207 articles by views in Open forum infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 207 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract We present a case of emergent integrase strand transfer inhibitor resistance following rifamycin-based latent tuberculosis infection (LTBI) treatment in a patient with HIV. This case highlights the risks associated with modifying antiretroviral therapy during LTBI treatment and illustrates how archived genotype results can directly impact clinical decision-making.
| Reference Key |
openalex_W7170056354
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Emily Dyer, Shawnalyn W Sunagawa, Nichole N Regan, Jennifer M Davis, Sara H Bares |
| Journal | Open forum infectious diseases |
| Year | 2026 |
| DOI |
10.1093/ofid/ofag448
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.